Anavex Life Sciences Corp (AVXL)

[powerwalker]

Hoskuld, TGD mention some time back that Anavex was conducting pricing talks with some of the EU countries. So, along with the other repliers, it might not be that long, especially if a European BP is the partner (Consortium member Lundbeck, comes to mind).

As to ¶2, NYT reports that fda is not reviewing any new drugs. Whether those awarded vouchers are included is anyone's guess.

Then there are the services those workers aren’t providing, including national park tours and new drug reviews, that support commerce. For many businesses, the timing couldn’t be worse, with the holiday season approaching and economic uncertainty already high.

See ¶4 in:
https://www.nytimes.com/2025/10/21/business/economy/government-shutdown-economic-effects.html?smid=nytcore-ios-share&referringSource=articleShare